Extending Drug Monopolies by Patenting Safe Drug Use

被引：3
作者：
Bloomfield, Doni [1 ,2 ]
Walsh, Bryan S. [1 ,2 ]
Kesselheim, Aaron S. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JAMA INTERNAL MEDICINE | 2022年 / 182卷 / 03期
关键词：
D O I：
10.1001/jamainternmed.2021.7954
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：245 / 246
页数：2
相关论文
共 8 条
[1]  
Center for Drug Evaluation and Research, APPR PACK APPL NUMB
[2]  
European Patent Office, 133051300 EUR PAT OF
[3]  
IFI Claims Patent Service, METH RED RISK ADV TE
[4]  
Jazz Pharmaceuticals, ANN REP 2021
[5]  
Sanofi, FORM 20 F
[6]  
US Food and Drug Administration, PET APPR LETT FDA CD
[7]   A Court Decision on "Skinny Labeling" Another Challenge for Less Expensive Drugs [J].
Walsh, Bryan S. ;
Bloomfield, Doni ;
Kesselheim, Aaron S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14) :1371-1372
[8]  
World Health Organization, GAMM HYDR AC GHB CRI
1